Tag: Pfizer
Pfizer acquires 8.1% of Valneva after partnership on Lyme vaccine
(Finance) – PfizerUS pharmaceutical company, will invest 90.5 million euros in ValnevaFrench biotechnology company, acquiring 8.1% of the capital at a price of € 9.49 per share, through a reserved…
Covid-19: ongoing evaluation of a modified Pfizer vaccine targeting Omicron
News Posted 15 hours ago, Reading 2 mins. The European Medicines Agency has just launched an evaluation procedure for a modified version of Pfizer’s anti-Covid vaccine. It would aim more…
Fact-checking with a Pfizer twist
In order to fight against misinformation, social networks and major media have decided to tackle “fake news”. But the “verifiers” do not necessarily have the skill and talent to distinguish…
“Pfizer documents”: no, there are not 9 out of 10 women vaccinated against Covid who lose their babies
News Published 2 days ago, Reading 3 mins. in collaboration with Dr Gérald Kierzek (Medical Director of Doctissimo) This is fake news that is circulating widely on social networks. “Confidential…
Gene Therapy Step in the USA for Muscle Disease from Pfizer
Pfizer announced that they will begin clinical trials in the USA in experimental gene therapy studies for DMD, a type of muscle wasting disease. The announcement was made after the…
Pfizer buys ReViral for up to $ 525 million
(Finance) – The US pharmaceutical company Pfizer made a deal for acquire ReViral for a total consideration of up to $ 525 million. The acquired company is a biopharmaceutical company…
4th dose Covid vaccine: at 65, 80, with Pfizer, compulsory?
4TH DOSE. The vaccine booster reboosts the immune system and limits the serious forms of Covid-19. The HAS now recommends its administration from the age of 65. For who ?…
Pfizer vaccine in 5-11 year olds: effectiveness against contamination would drop to 12% with Omicron
News Posted 2 hours ago, Reading 2 mins. A new American study suggests a drop in the effectiveness of the Pfizer vaccine on the risk of contamination in children aged…
Paxlovid: European Medicines Agency approves Covid pill developed by Pfizer
The European Medicines Agency (EMA) has given conditional approval for the distribution of the pill called “Paxlovid”, developed by the US-based company Pfizer, against coronavirus, for use in severe patients…
Covid-19: we know how long the effectiveness of the 3rd dose declines
The third dose of the anti-Covid vaccine has been available to everyone since the end of November 2021. Here we are a few months later, what do we know about…